Quanta Dialysis Technologies
Alejandro Galindo is Chief Executive Officer of Quanta. Alejandro joined Quanta with over 25 years of experience in the healthcare, energy, and consumer industries. A career veteran known for his considerable expertise across a variety of leadership roles, Alejandro has an accomplished track record in product development, mergers and acquisitions, global expansion, and distribution strategies. Most recently, he served as executive vice president of the Endocrine Business Unit of MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases.
Prior to MannKind, Alejandro spent 6 years at Medtronic as vice president and president of the Advanced Insulin Management Business Unit, where he achieved double-digit growth within their diabetes division. Alejandro also spent 20 years at General Electric leading teams across the globe from the company’s diverse group of industries. He holds a Master of Science and Master of Business Administration from Indiana University Bloomington, and a Bachelor of Science in Engineering from Tecnológico de Monterrey.
This person is not in any teams
This person is not in any offices
Quanta Dialysis Technologies
Quanta aims to improve the lives of dialysis patients by providing advanced haemodialysis solutions for use in a range of care settings. SC+ is designed with you in mind and provides flexibility for patients, carers and providers. Our mission at qua...